Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Survey from Harbor Life Settlements Reveals Knowledge Gaps That May Be Costing Life Insurance Policyholders


At Harbor Life, we recognize the life insurance industry is complex, but we also believe it is vitally important people understand the wide range of financial benefits that come with having a life insurance policy.

Harbor Life Settlements, a company dedicated to helping people unlock the value of their life insurance by making the life settlement process straightforward and transparent, today announced the key results of its 2020 Life Settlement & Retirement Survey. Harbor Life conducted a national survey of 1,702 U.S. adults to better understand people’s knowledge of life insurance benefits and options, with the goal of uncovering insights that help individuals make better decisions around financial and retirement planning.

Overall, Harbor Life’s study revealed that while 70% of U.S. adults have life insurance, there are sizable knowledge gaps among consumers that may be preventing them from understanding the full potential of their policies. Looking specifically at those who have life insurance:

  • 43% of policyholders do not know they can sell their policy in a life settlement
  • 57% of policyholders do not know what a viatical settlement is
  • 11% do not know what type of life insurance they have

“These startling numbers show a large percentage of Americans are paying policy premiums each month, but are unaware of the full financial potential of their life insurance coverage, ” said Lucas Siegel, Founder and CEO of Harbor Life Settlements. “At Harbor Life, we recognize the life insurance industry is complex, but we also believe it is vitally important people understand the wide range of financial benefits that come with having a life insurance policy. In fact, we know if Americans took full advantage of life settlements, that benefit alone could close nearly half of the current $130 billion deficit between federal retirement funding and long-term care expenses for seniors.”

When it comes to Americans 55 and older, Harbor Life’s survey shows one in five retired seniors do not feel they have enough money to cover their medical, living and retirement expenses comfortably. In fact, retired seniors are 900% more likely to be concerned about having enough money to cover their expenses when compared to retirees under the age of 55. Conversely, the largest consumer knowledge gap around life and viatical settlements resides with seniors. Sixty-three percent of seniors do not know what a life settlement is, compared to 53% of people 54 or younger, and 75% of seniors do not know what a viatical settlement is, relative to 66% of non-seniors.

“These findings are unfortunate considering seniors are the most likely group to be eligible for a life settlement. Also knowing 20% of retired seniors are struggling to comfortably cover their expenses, while more than two-thirds of them still carry an active life insurance policy, makes it imperative that we close the knowledge gaps discovered in our study,” added Siegel. “We view these findings as an opportunity to work closely with both consumers and financial advisors to improve knowledge and awareness around life settlement options and other living benefits of life insurance.”

For additional survey findings related to consumer motivations for having a life insurance policy, measurements of how life insurance needs evolve over one’s life, what factors prevent Americans from buying life insurance policies, and more please click here.

About Harbor Life Settlements

Harbor Life Settlements is a life settlement company that is dedicated to helping seniors and the terminally or chronically ill sell their life insurance policies for maximum cash value so they can comfortably afford their long-term care, medical expenses, retirement, and more. To make the life settlement process easy and transparent, Harbor Life handles all underwriting, paperwork, and legal matters associated with the sale of a life insurance policy, and works with a large network of fully-licensed life settlement brokers and providers to guarantee the highest cash offer for every client. To learn more, please visit harborlifesettlements.com.

Share article on social media or email:

Encompass Introduces the COVAIRE™ Clear Barrier Drape, Compliments PPE Reducing Risks


COVAIRE from Encompass is a simple, innovative, easy-to-use way to help protect caregivers from COVID-19 airborne particles.

“Due to recent findings, there is an increased focus on finding ways to protect healthcare workers and operating room personnel from exposure to COVID-19.” – Kristy Warren Encompass Group Director, Clinical Resources

Encompass Group, LLC announces COVAIRE™, an innovative new product that helps contain viral aerosols using a clear plastic disposable barrier. COVAIRE provides visual access with ease of maneuverability while further protecting the healthcare worker from aerosolized particles during high risk aerosol-generating procedures. It’s an additional layer of protection to compliment providers’ current PPE.

COVAIRE is generously sized – adequate length and girth for a bariatric patient – and made of a clear, medical grade film that’s safe, comfortable, and lightweight. With its contoured silhouette, COVAIRE tucks under the patient’s head, covering the temporal and ear regions. A curved opening on each side allows the provider to insert his/her arms for a full range of movement without restriction when operating an apparatus, intubating or extubating. COVAIRE does not move while in use. Once a procedure is complete, COVAIRE folds up, aerosolized viral particles are contained on the product and can be safely disposed of.

COVAIRE’s cost-effective, small individual package size allows it to be stored for easy access in code, respiratory, and anesthesia carts. It can be utilized in all patient care areas: OR, ICU, ED, In-patient, Out-patient, and Cardiology.

Kristy Warren MSN-Ed, RN, BA, CLLM Director, Clinical Resources Encompass Group, LLC says, “Due to recent findings, there is an increased focus on finding ways to protect healthcare workers and operating room personnel from exposure to COVID-19. Research indicates that mobilization of the virus by aerosol generating procedures, such as intubation, extubation, TEE, CPR, and EGD may pose a significant risk to caregivers. Aerosol generating procedures should be regarded as a time when production of airborne particles and aerosolization of the virus is highest.”

Studies from the New England Journal of Medicine have recently proven that once aerosolization occurs, airborne particles containing the live virus may be suspended in the air for up to three hours creating increased opportunities for healthcare worker exposure. COVAIRE is a simple, innovative, easy-to-use way to help protect caregivers.

About Encompass Group

Encompass is one of the world’s leading manufacturers and marketers of reusable textiles, professional apparel, and disposable and single use medical products. Encompass believes that every patient, resident, caregiver, and family member should feel safe and comfortable in today’s healthcare environments. The way Encompass enhances the healthcare experience is by developing innovative products that are reliably delivered and cost effective for all providers.

The markets we serve include Acute Care, Long-Term Care/Senior Care, Retail Health Care Apparel, Hospitality, and Government Operations. For more information, please visit http://www.encompassgroup.com, email info@encompassgroup.net, or call (800) 284-4540.

Share article on social media or email:

Mitotherapeutix Announces Positive Results from Pre-Clinical Liver Biopsy Study in Cynomolgus Monkeys


News Image

Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the mitochondrial regulator MCJ, today announced that it has successfully completed an in vivo chronic study in cynomolgus monkeys to suppress expression of MCJ, a new and novel target that regulates mitochondrial metabolism. The results of the study showed steady suppression in MCJ expression using a GalNAc conjugated siRNA. The GalNAc technology to deliver the siRNA to the liver as well as the nucleotide sequences were developed and discovered by MITO. The level of MCJ suppression at four weeks was approximately 70%, consistent with the standard set by other siRNA candidates in development as well as FDA approved.

“Demonstrating significant efficacy in non-human primates is an important milestone in siRNA drug discovery and development,” said Jack Talley, Chief Executive Officer, MITO. “We developed the GalNAc delivery platform and siRNA targeted MCJ in-house and are delighted with the outcome of this successful study as a new and novel means to potentially treat NASH. There is a significant unmet medical need in this area that we hope to fill. Based on our assessment of the data, we intend to meet with the FDA for a pre-submission meeting early next year.”

The Company is seeking funding by way of government grants, commercial partnerships or the sale of equity in order to advance the MCJ platform forward.

About NASH:

The liver is an organ which detoxifies various metabolites, synthesizes proteins and produces biochemicals necessary for digestion and growth. The normal liver does not store fat, but fat can be found in individuals that have Nonalcoholic Fatty Liver Disease (NAFLD). If there is hepatitis (inflammation) in addition to fat accumulation, then the disease is recognized as Nonalcoholic Steatohepatitis (NASH). According to the National Institute of Diabetes and Digestive and Kidney Diseases (NDDK) as many as 30% to 40% of Americans have NAFLD and about 3% to 12% have NASH. Dietary changes and weight loss can be of major help in the treatment of NASH but occurs in only a small number of individuals. There is major activity in drug discovery and development for NAFLD and NASH. Thus far no drug has been approved. We believe we may have such a drug. Our approach is enhancing the metabolic activity in the mitochondria. We do this by enhancing the electron transport chain (ETC) in mitochondria and have demonstrated the efficacy of this approach in several animal models that reduce liver fat.

About Mitotherapeutix LLC:

Mitotherapeutix is a US-based pre-clinical stage pharmaceutical company that is developing drugs (siRNA) targeting metabolism to treat disease. Our initial program targets a protein MCJ/DNAJC15, found in the mitochondria and is responsible for enhancing the production of energy. MCJ is unusual because it is a negative regulator of metabolism and knocking out MCJ enhances the electron transport chain (ETC) and the production of ATP without increasing reactive oxygen species (ROS). Enhancing the production of energy corrects the imbalance of fat, inflammation and fibrosis in the liver. MCJ is also present in other tissues besides the liver including the kidney and the heart. For more information, please visit http://mitotherapeutix.com.

MITO Disclosure Notice: This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein, or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forward looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative or other variations thereof or comparable terminology are intended to identify forward looking statements. Investors are cautioned that all forward-looking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or other events outside of the Company’s control.

Investors are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. The Company undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

Share article on social media or email:

Periodontist in Eden Prairie, MN, Restores Bone Loss with Ridge Augmentations at PerioWest


Dr. Andres Sanchez, Board-Certified Periodontist in Eden Prairie, MN

Dr. Andres Sanchez Offers Specialized Treatment for Bone Loss in Eden Prairie, MN

Dr. Andres Sanchez, a board-certified periodontist at PerioWest, invites patients with bone loss in Eden Prairie, MN to experience the benefits of personalized ridge augmentation, including restored function, oral health, and natural smile aesthetics. He now welcomes patients, especially those with severe bone loss, to schedule an appointment with or without a referral.

Jawbone loss naturally occurs when one or more teeth are lost or extracted. In other cases, bone loss can be attributed to oral trauma, disease or cancer, and genetic abnormalities. The most common cause, missing teeth, is a result of no tooth roots, which provide the stimulation the jawbone needs to maintain healthy volume and density. The resulting bone atrophy leaves the bone feeble and thin, unable to support restorations such as dentures or dental implants. Bone loss in the jaw can be contained to an empty tooth socket or extend along a portion of the jaw ridge. In both cases, specialized ridge augmentation is needed to restore the necessary bone to the jaw. This is commonly completed before dental implant placement to ensure their long-term stability and function.

Ridge augmentation refers to a specialized bone grafting treatment that adds bone material to the jaw to increase the height and width of the bony ridge. This complex procedure requires the expertise of a periodontist like Dr. Sanchez to ensure the natural jaw ridge contours are restored to proper density and volume. Bone loss because of a single missing or extracted tooth can be unsightly and cause aesthetic issues if replaced by a dental bridge or dental implant. In this case, ridge augmentation can restore aesthetic bone levels and smooth the bone for a future restoration.

The most beneficial restoration, dental implants permanently restore tooth function and aesthetics while preserving bone to maintain oral health. They replace one, several, or all missing teeth with permanent “tooth roots” (implant posts) and a dental crown, dental bridge, or fixed set of teeth. PerioWest offers the expertise of Dr. Sanchez and his associate, prosthodontist Dr. Eleni Voltidi, who together provide life-changing smile transformations with dental implants.

Patients with bone loss in Eden Prairie, MN interested in learning more about the benefits of bone grafting treatments including ridge augmentations can contact this esteemed periodontist. Consultations can be scheduled, with or without a referral, at PerioWest by visiting http://www.periowestmn.com or calling 952-567-7457.

About the Practice

PerioWest is a periodontal practice offering personalized dental care for patients in Eden Prairie, MN and the Twin Cities areas. Dr. Andres R. Sanchez received his Certificate & Master’s Degree in Periodontics from the prestigious Mayo Clinic in Minnesota. He is a board-certified periodontist and a Diplomate of the American Board of Periodontology. In addition, Dr. Sanchez has been involved as a primary author in more than ten scientific papers published in major periodontal and implant dentistry journals. His associate, Dr. Eleni Voltidi is a prosthodontist who completed her Fellowship in Dental Oncology and Maxillofacial Prosthetics from the prestigious Mayo Clinic in Minnesota. PerioWest provides state-of-the-art dental implant treatment, LANAP® laser therapy, and advanced periodontal care to Eden Prairie, MN and the Twin Cities areas. To learn more about Dr. Sanchez and the services provided at PerioWest, please visit the practice website at http://www.periowestmn.com or call 952-567-7457.

Share article on social media or email:

Focal Healthcare Receives Funding to Advance Product Development


The support will allow us to incorporate elements of artificial intelligence and automation into this new device and other products that will make them even easier to use and more accurate.

Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it is receiving advisory services and research and development funding of up to $200,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

The contribution will support the research and development of a new transperineal prostate fusion platform that allows physicians to better target specific areas of the prostate for the purpose of diagnosing and treating prostate cancer. By offering a highly targeted approach to managing prostate cancer, patients can get more timely diagnoses and receive focalized treatment that has the potential to improve their standards of living.

“We are grateful for the advice and funding support from NRC IRAP as it will help us accelerate the research and development of our transperineal platform,” said Chicuong La, CEO of Focal Healthcare. “The support will allow us to incorporate elements of artificial intelligence and automation into this new device and other products that will make them even easier to use and more accurate.”

Focal Healthcare’s current product, Fusion Bx 2.0, combines information from multiparametric MRI with a semi-robotic arm and user-friendly interface to give physicians the ability to perform targeted prostate biopsies. Fusion Bx 2.0 is cleared for sale in Canada, USA, the EU and Taiwan.

This project will support the development of a fully automated transperineal MRI fusion device towards enabling clinical trials.

About Focal Healthcare Inc.

Focal Healthcare is a Canadian-based medical device company committed to improving the lives of prostate cancer patients and their families through technical innovation. By developing imaging tools that emphasize accuracy, efficiency and accessibility, Focal Healthcare strives to advance prostate cancer diagnosis and management in clinics and hospitals of all sizes. Focal Healthcare designs and manufactures all its products at its headquarters in Toronto, Canada.

Share article on social media or email:

Global Wellness Summit Partners with Wellness Community Pioneer Serenbe for Post-Summit Wellness Real Estate & Communities Immersion Experience


The Global Wellness Summit has teamed with pioneering wellness community Serenbe to offer 2020 delegates the opportunity to fully immerse themselves in a unique wellness community experience.

To have the chance to literally share the Serenbe experience and business model with Summit delegates—including insight into how we overcame obstacles over the years and guidance on what we believe the successful components of a winning wellness community are…”

The Global Wellness Summit (GWS), the foremost gathering of international leaders in the multi-trillion-dollar global wellness economy, has teamed with pioneering wellness community Serenbe to offer 2020 delegates the opportunity to fully immerse themselves in a unique wellness community experience. Situated among acres of forests and meadows on the edge of Atlanta—with miles of trails connecting homes and restaurants with arts and businesses—award-winning Serenbe sets the standard for wellness communities. The two-day experience kicks off November 11, after the 14th annual Summit, which takes place at The Breakers Palm Beach, Florida, from November 8–11, 2020.

“The theme of the 2020 Summit, ‘Resetting the World with Wellness,’ is a global call to action to recognize that more comprehensive and inclusive wellness concepts could remake the world post-pandemic,” said Susie Ellis, chair and CEO of the Global Wellness Summit.

“We believe that communities centered on wellness will play a huge part in resetting our world, and Serenbe represents the gold-standard—a wellness community that has delivered on its original vision, but that has also continued to innovate and thrive in an ever-evolving landscape. This behind-the-scenes visit will give Summit delegates invaluable access and insight into what makes Serenbe such a success story,” said Ellis.

Real estate experts increasingly agree that wellness real estate is emerging as one of the big economic winners during the pandemic and that homes designed for human health will be a core driver of the global real estate market going forward. The two-day immersion is designed to give Summit delegates an opportunity to learn and experience what makes this unique wellness community both a commercial and personal success story for its founders.

“To have the chance to literally share the Serenbe experience and business model with Summit delegates—including insight into how we overcame obstacles over the years and guidance on what we believe the successful components of a winning wellness community are—is something I’m very much looking forward to,” said Steve Nygren, founder of Serenbe along with his wife, Marie Lupo Nygren.

Wellness Real Estate Gains Momentum

In 2018, GWI researchers forecasted that the wellness real estate and communities market would be the fastest-growing wellness segment over the next few years: expanding from a $134 billion market in 2017 to $198 billion by 2022 (or 8% annually)**. Those numbers may be surpassed given the COVID-19 crisis, which has rapidly accelerated people’s desire to bring far more wellness into their homes and to live in intentionally wellness-focused communities. GWI’s Build Well to Live Well research reported that there were roughly 750 global wellness real estate/communities projects built or in the development pipeline in 2018; GWI researchers expect that number to grow significantly.

Coldwell Banker’s “The Report: 2020,” on current high-end real estate trends, analyzes how “wellness is the new ‘it’ amenity,” and “Builder magazine” recently noted that wellness real estate has moved from “elective to essential…due to COVID-19.” Experts also point out that the pandemic will help move this market to increasingly innovative, super-sophisticated new developments that tackle a holistic concept of wellness—both on the human health and environmental front.

Serenbe Post-Summit Retreat

Summit delegates will attend a special reception at the Serenbe founders’ home and get a behind-the-scenes tour of Serenbe’s four hamlets, which all feature complementary commercial centers focused on the elements of a well-lived life: arts for inspiration, agriculture for nourishment, health for wellbeing, and education for awareness.

Delegates will stay at The Inn at Serenbe, set on a 36-acre farm, and, in addition to getting a private look behind the curtain, will also experience life as a Serenbe resident, choosing from an extensive list of classes and activities and dining on delicious, healthy cuisine made with fresh ingredients from their 25-acre organic farm.

To learn more about the Post-Summit Wellness Real Estate & Communities immersion at Serenbe, click here.

To learn more about the Summit or to register, click here.

About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. The 14th annual Summit will take place at The Breakers Palm Beach, FL, from November 8–11, 2020. The 2021 GWS will be held in Tel Aviv, Israel, November 15–18.

About Serenbe: Founded by the Nygren family in 2004, Serenbe is a biophilic community connected to nature on the edge of Atlanta. The community of 750 residents and growing is set among acres of preserved forests and meadows with miles of nature trails that connect homes and restaurants with arts and businesses. Focused on wellbeing, Serenbe is a neighborhood with fresh food, over 300 days of arts and cultural programming, multiple independent shops, an artist residency program, a 27-room Inn, four restaurants and a working organic farm. The best reason to live here is the life here. serenbe.com

** https://globalwellnessinstitute.org/what-is-wellness/what-is-wellness-lifestyle-real-estate-communities/ **

Share article on social media or email:

RidgeCrest Herbals’ ClearLungs Liquid Wins Taste For Life Magazine’s Back to School Immunity Award


RidgeCrest Herbals is thrilled to have their ClearLungs Liquid included in the category of Immunity Support. The honor of this award has been granted to ClearLungs Liquid two years running, having earned this award in 2019 as well.

Whatever form of learning each school district has chosen to adopt this year, everyone involved, from parents to teachers and administrators, shares the top priority of keeping kids healthy and safe. With that in mind, the New Hampshire-based Taste For Life Magazine has published its annual Back to School product awards for 2020. RidgeCrest Herbals is thrilled to have their ClearLungs Liquid included in the category of Immunity Support. The honor of this award has been granted to ClearLungs Liquid two years running, having earned this award in 2019 as well.

“We are thrilled that RidgeCrest Herbals has been honored with this award a second year in a row,” says Nichole Petersen, RidgeCrest Herbals’ marketing director. “Our ClearLungs Liquid provides immune support for kids in an easy-to-swallow orange-flavored liquid, making it painless for parents and kids alike. Winning this award is a testament to our team’s hard work to create a product that is both effective and worthy of kids’ approval.”

This award comes at a crucial time when, more than ever, parents are looking for ways to keep their kid’s immunity at its peak. “We can’t thank Taste for Life enough for choosing us as a back to school essential product winner,” says Chris Herbert, Director of Sales. “We feel honored to be included with many other great companies helping consumers stay healthy during these times.”

RidgeCrest Herbals based ClearLungs Liquid on a remedy of thirteen ingredients effectively used in Traditional Chinese Medicine for nearly 2,000 years. The ClearLungs Liquid product is part of RidgeCrest Herbals’ ClearLungs Family, including ClearLungs Original, Extra Strength, ClearLungs Immune, and ClearLungs Sport.

Nestled in the shadow of the Wasatch Mountains, Ridgecrest Herbals brings effective, eclectic, innovative botanical blends drawn from ancient global traditions to U.S. consumers. Seller of the #1 selling natural lung product ClearLungs, RidgeCrest Herbals has been helping you “Reach Your Peak” since 1994.

Share article on social media or email:

The Importance of Keeping Digital Instruction Consistent with School Goals


News Image

The COVID-19 pandemic has given the entire country a crash course in virtual education and digital education platforms. As school buildings closed in the spring of 2020, school leaders scrambled to implement virtual education programs. This was both a necessary response to the current crisis and, for virtual education advocates, an opportunity to permanently transform public education with digital technology.

Unfortunately, school leaders have had little more than marketing messages to inform their considerations of digital offerings. To provide some additional information, insights and recommendations, NEPC released a three-brief collection today. Issues to Consider Before Adopting a Digital Platform or Learning Program was authored by Faith Boninger and Alex Molnar of the University of Colorado Boulder, with contributions by Michael Barbour of Touro University California. The briefs detail how digital platforms and learning programs can distort curriculum, teaching, and assessments, threaten student privacy, and undermine data security. They identify key issues for school leaders to consider before adopting digital programs.

Each brief includes recommendations unique to its specific focus as well as recommendations common across the collection. The framing principle underlying all three briefs is that school leaders should ensure that any digital technology they adopt reflects, rather than undermines or distorts, their school’s stated values and goals. In the context of the pandemic, the best many school leaders can do is minimize any potential harm that may result from the need to hastily adopt digital technologies. With this in mind, the authors offer the following principles to guide decision-making.

Digital learning programs and platforms are less likely to harm students to the extent that they:


  • Retain curriculum and teaching practices consistent with school goals and values;
  • Have been reviewed for bias by i- ndependent experts;
  • Maintain teachers’ control of educational decisions rather than transfer those decisions to algorithms programmed into applications;
  • Collect a minimal amount of student data; and
  • Prevent the transfer of student data to vendors and other unknown parties.


These principles, in conjunction with the considerations detailed in each brief, can be used to help determine which digital products to choose, how to best use them in the current crisis, and how to decide which should be abandoned when the crisis has passed.

Find Issues to Consider Before Adopting a Digital Platform or Learning Program, by Faith Boninger and Alex Molnar, at:

http://nepc.colorado.edu/publication/virtual-learning

The National Education Policy Center (NEPC), a university research center housed at the University of Colorado Boulder School of Education, produces and disseminates high-quality, peer-reviewed research to inform education policy discussions. Visit us at: https://nepc.colorado.edu

Share article on social media or email:

180 Medical Announces 2020 Scholarship Recipient Winners


News Image

180 Medical takes tremendous pride in supporting the educational pursuits of our awardees. The candidates we review each year continue to raise the bar. We are inspired and energized by these applicants, especially when overlaying the complexities of managing their own condition.

180 Medical, one of America’s leading providers of intermittent catheters, ostomy supplies, and incontinence products, is pleased to announce this year’s recipients of the annual 180 Medical College Scholarship.

When 180 Medical’s founder, Todd Brown, created the scholarship program, it was his hope to be able to help young students and their families offset the costs of higher education in order to achieve their dreams despite the financial burden that their health conditions might create for them.

This program provides seven recipients with $1,000 scholarship awards each year in order to help them finance their college education. Each student chosen must be a full-time student and under a doctor’s care for a spinal cord injury, spina bifida, transverse myelitis, neurogenic bladder, or an ostomy (ileostomy, urostomy, or colostomy). Those interested can learn more about the scholarship program at http://www.180medical.com/scholarships.

“180 Medical takes tremendous pride in supporting the educational pursuits of our awardees. The candidates we review each year continue to raise the bar. We are inspired and energized by these applicants, especially when overlaying the complexities of managing their own condition,” said Seth Segel, President of 180 Medical.

In 2020, 180 Medical received applications from hopeful students all over the United States, and as always, it was a difficult choice for the committee to begin narrowing down to the final seven recipients. While each one of our recipients come from different backgrounds and have different career goals, they all are looking to create a brighter future for themselves and their families.

The seven finalists who have received the $1,000 scholarship award are:

  • Alexander Coleman (Purdue University)
  • Brandon Staple (University of Colorado – Denver)
  • Heidi Pearson (Boise State University)
  • Lillian Droscha (Hope College)
  • Matthew Schultz (University of Nebraska – Omaha)
  • Reo Hayashizaki (University of Oklahoma)
  • Tashiana Scott-Cochran (North Carolina Central University)

180 Medical would like to thank everyone who applied. All applicants are encouraged to apply again in 2021. Congratulations to the 2020 180 Medical College Scholarship recipients!

About 180 Medical:

180 Medical is one of America’s fastest growing home delivery providers of intermittent catheters, ostomy products, incontinence supplies, and other related urologic disposable medical supplies. Based in Oklahoma City, the company is dedicated to meeting the supply needs of customers with diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn’s disease, and many other conditions that require catheterization and ostomy supplies. 180 Medical is a subsidiary of ConvaTec, a leading global medical products and technologies company. For more information, please visit http://www.180medical.com.

Share article on social media or email:

New medical software powered by AI aids diagnosis of autoimmune diseases


News Image

It is an enormous leap in quality to the technique, since it achieves that the reading is done in a systematic way

Capillary.io is a new software that uses today’s deep learning techniques to improve the medical practice of nailfold capillaroscopy, a diagnosis process that consists of examining with a microscope the blood capillaries at the base of the nails of each finger of a patient.

By looking at capillaries, doctors can assess the health of the patient’s blood circulation, find abnormal capillaries, capillary loss, etc. which can lead to conditions such as scleroderma and dermatomyositis.

Capillary.io is a new tool that improves capillaroscopy efficiency, objectiveness and boosts research by using AI to automatically detect, measure and classify capillaries by its shape and size, and also give useful and comprehensive metrics to doctors.

This is the first tool, in internal medicine and rheumatology, to offer automation advantages to capillaroscopy, a well established technique that lacked proper tools. In the words of Dr. Patricia Fanlo, a user of Capillary.io and coordinator of GEAS-SEMI: “This tool allows us to speed up, improve and facilitate the performance and usefulness of capillaroscopy, systematizing and analyzing the clinical information obtained. We can obtain reports with clinical parameters quickly and easily that guide us in the diagnosis, for example, of diseases such as scleroderma, by studying the microcirculation of the capillaries near the base of the patient’s nail”.

Related topics: machine learning, deep learning, computer aided diagnosis, internal medicine, rheumatology, autoimmune diseases, microcirculation.

Share article on social media or email: